Quantcast
Home > Quotes > CMTA

Clementia Pharmaceuticals Inc. Common Shares (CMTA) Quote & Summary Data

CMTA 
$9.8
*  
0.29
3.05%
Get CMTA Alerts
*Delayed - data as of Aug. 21, 2018 13:58 ET  -  Find a broker to begin trading CMTA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    CMTA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 9.53 / $ 9.96
1 Year Target
26
Today's High / Low
$ 10.17 / $ 9.52
Share Volume
54,591
50 Day Avg. Daily Volume
106,349
Previous Close
$ 9.51
52 Week High / Low
$ 20.15 / $ 8.1001
Market Cap
310,832,323
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -2.96
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.98

Intraday Chart

Shares Traded

Share Volume:
54,591
50 Day Avg. Daily Volume:
106,349

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.96

Trading Range

The current last sale of $9.80 is 20.99% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 10.17 $ 20.15
 Low: $ 9.52 $ 8.1001

Company Description (as filed with the SEC)

Clementia Pharmaceuticals Inc. was incorporated under the CBCA on November 5, 2010. The principal executive offices of Clementia Pharmaceuticals Inc. are currently located at 4150 Sainte-Catherine Street West, Suite 550, Montreal, Quebec, Canada H3Z 2Y5. Our telephone number is (514) 940-3600. 50 Clementia Pharmaceuticals Inc. has a wholly-owned subsidiary, Clementia Pharmaceuticals USA Inc., which was incorporated in the state of Delaware, with a registered office located at 275 Grove Street, Suite 2-400, Auburndale , Massachusetts 02466 USA. On April 10, 2013, the Company closed a $22.5 million Class A financing led by OrbiMed, with a participation from an existing investor, BDC. On October 7, 2014, the Company secured an additional $10.2 million from its current investors to support the development of its lead compound palovarotene for the treatment of FOP thus bringing the total amount raised in the Class A financing to $32.7 million.  ... More ...  


Risk Grade

Where does CMTA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 9.72
Open Date:
Aug. 21, 2018
Close Price:
$ 9.51
Close Date:
Aug. 20, 2018

Consensus Recommendation

Analyst Info